D-0897-2018 Class II Terminated
FDA drug recall D-0897-2018 was initiated by SCA Pharmaceuticals, LLC on Jun 14, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage. The recall status is terminated (terminated Feb 4, 2019). Affected quantity: 2,869 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 11, 2018
- Initiation Date
- Jun 14, 2018
- Termination Date
- Feb 4, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,869 bags
Product Description
Diltiazem HCL 1 mg/mL in 125 mL 0.9% Sodium Chloride 100 mL bag (total volume 125 mL) (125 mg), SCA Pharmaceuticals, LLC, Windsor, CT
Reason for Recall
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Distribution Pattern
Product was distributed throughout the United States.
Code Information
Lot # 1218001315, 1218001316, 1218001349, 1218001416, 1218001510, 1218001682, 1218001683, 1218001684, 1218001721, 1218001763, 1218001764, Exp 07/26/2018-08/27/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0897-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026